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To investigate whether angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism is related to the risk of oral
precancerous lesions (OPL) in Taiwanese subjects who chew betel quid, a total of 61 betel quid chewers having OPL were compared
with 61 asymptomatic betel quid chewers matched for betel quid chewing duration and dosage. The frequency of homozygote for
ACE D variant is significantly higher in the case subjects than that of the controls (44.3 vs 24.6%; P¼0.0108). The adjusted odds ratio
of the D homozygous for the risk of OPL is 8.10 (95% confidence interval (CI)¼2.04–32.19, P¼0.003). In the allelic base analysis,
the D allele is also significantly associated with higher risk of OPL. When grouping the study subjects by smoking status, the
association between ACE I/D polymorphism and risk of OPL was only observed in nonsmokers. Our results support the theory that
genetic factors may contribute to the susceptibility of OPL and suggest that smoking and genetic factors may be differently involved in
the development of OPL.
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Both oral submucous fibrosis (OSF) and oral leukoplakia (OL) are
chronic potentially malignant lesions of the oral cavity, the former
being characterised by a submucosal fibrosis, resulting in marked
rigidity and progressive difficulty in opening the mouth, the latter
by chronic white mucosal maculae (Cox and Walker, 1996; Aziz,
1997). The most common oral premalignancies appear to be
related to the habit of chewing betel quid, tobacco smoking and
heavy alcohol consumption (Cox and Walker, 1996; Yang et al,
2001; Lee et al, 2003; Avon, 2004; Sikdar et al, 2004). These are
chronic inflammatory and immunologic processes, which are
believed to be attributable to the collective effect of genetic
predisposing susceptibility in combination with specific environ-
mental factors (Nair et al, 1999; Chiu et al, 2001, 2002; Kao et al,
2002; Liu et al, 2004; Shin et al, 2004; Sikdar et al, 2004; Tsai et al,
2004).
Angiotensin-converting enzyme (ACE) is expressed in a wide
range of tissues (Smallridge et al, 1986; Noveral et al, 1987; Petrov
et al, 2000) and converts angiotensin I to the potent vasocon-
strictor angiotensin II (Ang II). The latter may be involved in the
fibrotic process because it acts as a proinflammatory cytokine,
participating in various steps of the inflammatory response
(Mezzano et al, 2001). Studies have also demonstrated that ACE
insertion/deletion (I/D) polymorphism is associated with fibrotic
and atherosclerotic cardiovascular disease (Mezzano et al, 2001;
Morrison et al, 2001; Arkwright et al, 2003; Luther et al, 2003).
Thus, ACE might be a candidate gene for OSF and OL. We
therefore investigated the role of ACE gene I/D polymorphism in
relation to the risk of OSF and OL in the aboriginal population of
Taiwan, which has a high prevalence of betel quid chewing.
MATERIALS AND METHODS
Recruitment of study subjects
Between January 2001 and December 2003, the Taiwan Bureau of
National Health Insurance conducted the Taiwan Aboriginal
Health Interview and Integrated Health Care Program in rural
indigenous people over 30 years old. Using population registries, a
total of 826 residents were screened for oral mucosal lesions in a
Pai-wan tribe community in Pingtung County. Oral OSF and OL
lesions were diagnosed on the basis of past history, oral
examination and pathologic confirmation of the lesions according
to the World Health Organisation (WHO) criteria (Wahi et al,
1966).
All study subjects lived in the same region at the time of the
study and were of Pai-Wan ethnicity without known ancestry from
other ethnicities. This study was approved by the Human Research
Ethics Committee of our hospital, and informed consent was
obtained from each participant. Each subject was interviewed face
to face about demographic information, occupation, betel quid
chewing, smoking history and alcohol drinking habits, as well as
personal and family history of various cancers. The age at which Received 22 April 2005; revised 8 July 2005; accepted 13 July 2005
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age at which the habit was stopped were queried in detail for betel
quid chewing, cigarette smoking and alcohol drinking. Cumulative
exposure to betel quid chewing was derived by multiplying the
daily consumption of betel quid chewing (in quid/day) by the
duration of betel quid chewing (in years). Valid questionnaires
were examined further by a structured questionnaire. Blood
pressure, body height and weight were measured and body mass
index (BMI) was calculated. Blood was also collected; serum and
white blood cells (WBCs) were separated on the day of blood
collection and frozen at  701C until subsequent analysis.
Laboratory analysis
Genomic DNA was prepared from peripheral blood using standard
techniques. For the ACE I/D polymorphism, the primer pairs
used and the annealing temperatures were as follows: forward,
50-CTGGAGACCACTCCCATCCTTTCT-30; and reverse, 50-GAT
GTGGCCATCACATTCGTCAGAT-30, which amplify the intron
16 region where the I/D fragment is located. Polymerase chain
reaction (PCR) amplification products were obtained using 25ml
reactions (0.5pg genomic DNA, 500pmol of primers, 0.5mmoll
 1
each of deoxy-ATP, GTP, CTP, TTP and 1.5mmoll
 1 MgCl2; 0.5U
Taq DNA polymerase (Takara Tagt, Takara Shuzo Co., Ltd, Otsu
Shiga, Japan); 50mmoll
 1 KCl; 0.001% gelatin; 10mmoll
 1 Tris-
HCl, pH 8.3) with 4min of denaturation at 941C, followed by 35
cycles of 15s at 941C, 5s at 671C and 30s at 741C in a thermal
cycler (Gene Amp PCR System 9700, Perkin-Elmer, Foster City,
CA, USA). Reaction was terminated at 721C at 2min. To avoid ID/
DD mistyping of heterozygote as DD homozygote (Shanmugam
et al, 1993), all DD genotype samples were confirmed using a pair
of primers that produce an amplified product only in the presence
of the insertion, which was used to verify the polymorphism:
forward, 50-TGGGACCACAGCGCCCGCCACTAC-30; and reverse,
50-TCGCCAGCCCTCCCATGCCCATAA-30 (Lee and Tsai, 2002).
The PCR reaction condition was similar to the procedure for I/D
detection, except that the annealing temperature was 621C. All PCR
products were visualised after electrophoresis on a 2% agarose gel
and ethidium bromide staining. Genotyping was performed in a
blinded manner.
Statistical analyses
Data are shown as the mean7s.d. All statistical analyses were
performed using SAS statistical software (Version 8.2, SAS
Institute Inc., Cary, NC, USA). The two-sample t-tests or w
2 tests
were used to compare means and proportions between the groups
of control and oral precancerous lesions (OPL) when appropriate.
To determine whether an association existed between ACE
genotype and allele frequency with OPL risk, the significance of
the difference in the distribution of genotypes and alleles between
OPL patients and control subjects was calculated by w
2 statistic or
Fisher’s exact test and shown by P-value. All P-values were two-
sided. A P-value o0.05 was considered to be statistically
significant. Association of ACE genotypes and OPL was analysed
by conditional logistic regression of OPL patients vs controls
matched by betel quid chewing duration. To control the potential
confounding effects, sex, age, BMI, blood pressure, smoking and
drinking status were used as independent variables for adjustment.
Conditional logistic regression was carried out with the SAS
procedure PROC PHREG. Genotypic data entered the regression
model in the form of two dummy variables representing the effect
of genotype ACE I/D and genotype DD vs the reference category II,
respectively.
RESULTS
There were 185 subjects from a total of 826 rural indigenous people
who were found on screening to have oral mucosal lesions and
signed consent for further pathologic diagnosis. Among these, 111
subjects were confirmed to have OSF or OL; none had oral cancer,
while a total of 50 subjects were excluded, 21 because of missing
blood collection and 29 with missing information. Finally, a total
of 61 persons were included as case subjects, 10 with OSF, 26 with
OL and 25 OL with both lesions related to betel quid chewing. In
all, 61 betel quid chewers without any previous or present lesions
in the oral cavity matched for betel quid chewing duration and
dosage were used as control subjects. Table 1 presents the clinical
characteristics of study subjects. The mean age, gender distribu-
tion, BMI, blood pressure, amounts of quid consumption, drinking
rate and duration, smoking rate and duration were similar in both
Table 1 Clinical parameters in patients with OPL and control subjects
Parameters Patients with OPL Betel chewer control subjects P-value
Age (years) 56.7711.3 56.479.7 0.8839
Gender (male/female) 28/33 26/35 0.7154
BMI (kg/m
2) 28.075.1 27.475.0 0.5336
Systolic BP (mmHg) 144.3723.4 141.9725.6 0.5991
Diastolic BP (mmHg) 86.8713.0 83.1714.0 0.1493
Betel chewing duration (years)
1–20 16 (26.2) 16 (26.2) 1.0000
20–30 14 (23.0) 14 (23.0)
30+ 31 (50.8) 31 (50.8)
Cumulative amount of quid consumption
1–50000 11 (18.6) 11 (19.3) 0.2923
50000–100000 7 (11.9) 14 (24.6)
100000–200000 14 (23.7) 13 (22.8)
200000+ 27 (45.8) 19 (33.3)
Alcohol drinking (%) 45 (73.8) 41 (68.3) 0.5096
Drinking duration (years) 26.3710.2 26.6711.4 0.9040
Smoking (%) 17 (27.9) 19 (31.2) 0.6914
Smoking duration (years) 27.5713.2 29.0711.8 0.7190
OPL¼oral precancerous lesion; BMI¼body mass index; BP¼blood pressure. Data are expressed as mean7s.d.; comparisons performed by unpaired t-test or w
2 test when
appropriate.
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cumulative betel quid consumption amount were also similar
between the study groups.
The ACE gene I/D genotype distributions and allele frequencies
of the study groups are presented in Table 2. The genotype
distributions of this polymorphism were in Hardy–Weinberg
equilibrium both in the case and control groups. The distribution
of ACE genotypes in OPL patients was significantly different
(P¼0.0108) from that of controls. Patients with OPL had a higher
distribution of DD genotype or D allele frequency, indicating the
existence of a relationship between ACE gene polymorphism and
OPL risk. The association between ACE DD and ID genotypes and
risk of OPL still exist even after adjusting for age, gender, BMI,
systolic blood pressure, smoking and drinking status by condi-
tional logistic regression analysis (DD vs II: adjusted odds ratio
(OR)¼8.10, 95% confidence interval (CI)¼2.04–32.19,
P¼0.0030; ID vs II: adjusted OR¼3.69, 95% CI¼0.98–13.81,
P¼0.0530). When analysis was performed comparing the risk of
DD genotype vs II/ID genotype or ID/DD genotype vs II genotype
and D allele vs I allele, DD genotype or D allele still had a
significantly higher risk in the association with OPL (Table 2).
As previous reports have indicated that smoking status acts as a
contributing factor for OPL (Cahan et al, 1976), we further
subgrouped our study subjects according to their smoking status
to examine whether if affects the impact of ACE I/D polymorphism
with risk for OPL. The ACE gene I/D polymorphism was not
statistically different between smoking betel quid chewers with or
without OPL (Table 3), while the distribution of ACE genotypes in
nonsmoking betel quid chewers with OPL was significantly
different from that of those without OPL. Subjects with ACE DD
and ID genotypes were significantly associated with the risk of OPL
when adjusted for age, gender, BMI, blood pressure and drinking
status (DD vs II: adjusted OR¼14.62, 95% CI¼2.47–86.44,
P¼0.0031; ID vs II: adjusted OR¼6.97, 95% CI¼1.23–39.46,
P¼0.0282). Further analysis comparing the risk of DD genotype vs
II/ID genotype or ID/DD genotype vs II genotype and D allele vs I
allele showed that DD genotype or D allele had a significantly
higher risk in the association with OPL (Table 3).
Table 2 Comparison of ACE genotypes in patients studied
Parameters Patients with OPL Control subjects P-value
a Crude OR Adjusted OR
b P-value 95% CI
DD genotype (%) 27 (44.3) 15 (24.6) 0.0108 6.06 8.10 0.0030 2.04–32.19
ID genotype (%) 30 (49.2) 32 (52.5) 3.20 3.69 0.0530 0.98–13.81
II genotype (%) 4 (6.6) 14 (23.0) 1.00 1.00
DD genotype (%) 27 (44.3) 15 (24.6) 0.0222 2.40 2.85 0.0127 1.25–6.51
II/ID genotype (%) 34 (55.7) 46 (75.4) 1.00 1.00
ID/DD genotype (%) 57 (93.4) 47 (77.1) 0.0107 4.13 5.14 0.0115 1.44–18.32
II genotype (%) 4 (6.6) 14 (23.0) 1.00 1.00
D allele (%) 84 (68.9) 62 (50.8) 0.0041 4.20 5.26 0.0003 2.13–13.00
I allele (%) 38 (31.2) 60 (49.2) 1.00 1.00
ACE¼angiotensin-converting enzyme; OPL¼oral precancerous lesion; OR¼odds ratio; CI¼confidence intervals.
aComparisons performed by w
2 tests.
bAdjusted by sex, age,
body mass index, systolic blood pressure, smoking status and drinking status by conditional logistic regression analysis.
Table 3 Comparison of ACE I/D genotypes in patients studied grouped by smoking status
Parameters Patients with OPL Control subjects P-value
a Crude OR Adjusted OR
b P-value 95% CI
Smoker
DD genotype (%) 6 (35.3) 5 (26.3) 0.8148 1.50 2.57 0.4932 0.17–38.03
ID genotype (%) 9 (52.9) 12 (63.2) 1.10 1.39 0.8129 0.09–21.81
II genotype (%) 2 (11.8) 2 (10.5) 1.00 1.00
DD genotype (%) 6 (35.3) 5 (26.3) 0.5593 1.39 1.97 0.3955 0.41–9.45
II/ID genotype (%) 11 (64.7) 14 (73.7) 1.00 1.00
ID/DD genotype (%) 15 (88.2) 17 (89.5) 0.9060 1.28 1.97 0.6080 0.15–26.24
II genotype (%) 2 (11.8) 2 (10.5) 1.00 1.00
D allele (%) 21 (61.8) 22 (57.9) 0.7382 1.30 2.04 0.4563 0.31–13.31
I allele (%) 13 (38.2) 16 (42.1) 1.00 1.00
Nonsmoker
DD genotype (%) 21 (47.7) 10 (23.8) 0.0040 11.75 14.62 0.0031 2.47–86.44
ID genotype (%) 21 (47.7) 20 (47.6) 6.18 6.97 0.0282 1.23–39.46
II genotype (%) 2 (4.6) 12 (28.6) 1.00 1.00
DD genotype (%) 21 (47.7) 10 (23.8) 0.0209 2.80 3.15 0.0225 1.18–8.42
II/ID genotype (%) 23 (52.3) 32 (76.2) 1.00 1.00
ID/DD genotype (%) 42 (95.5) 30 (71.4) 0.0026 8.11 9.84 0.0074 1.85–52.51
II genotype (%) 2 (4.6) 12 (28.6) 1.00 1.00
D allele (%) 63 (71.6) 40 (47.6) 0.0013 8.38 10.19 0.0001 3.09–33.59
I allele (%) 25 (28.4) 44 (52.4) 1.00 1.00
ACE I/D¼angiotensin-converting enzyme insertion/deletion; OPL¼oral precancerous lesion; OR¼odds ratio; CI¼confidence intervals.
aComparisons performed by Fisher’s
exact test.
bAdjusted by sex, age, body mass index, systolic blood pressure, and drinking status by conditional logistic regression analysis.
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Although available epidemiological evidence indicates that the
chewing of betel quid is an important risk for the development of
OSF and OL (Avon, 2004; Yang et al, 2005), not all chewers develop
oral mucosal lesions (Yang et al, 2001). Molecular epidemiologic
studies have provided evidence that an individual’s susceptibility
to OSF and OL is modulated by both genetic and environmental
factors. Inherited differences in the effectiveness of the disease may
play a crucial role in host susceptibility (Chiu et al, 2002; Topcu
et al, 2002).
Our previous studies confirmed that betel quid chewing acts as a
major risk factor for OPL (Yang et al, 2001, 2005), while the
present study further indicates that genetic factors exist in the
vulnerability of betel quid chewing-related OPL. The additive used
for betel quid chewing in Taiwan is quite different from that of
India or Western populations. The betel quid in Taiwan does not
contain any tobacco (Yang et al, 2005), while tobacco is usually
added to betel quid chewed by Southeast Asians (Nandakumar
et al, 1990; Sankaranarayanan et al, 1990). The present study
shows that ACE gene I/D polymorphism is significantly associated
with betel quid chewing-related OPL both in nonadjusted and
adjusted models. To the best of our knowledge, this is the first
report showing that ACE gene I/D polymorphism is associated
with the risk of OPL in subjects who chew betel quid. Our results
support the evidence that genetic factors may interact with
environmental factors to contribute to the pathogenesis of OPL
(Sikdar et al, 2004; Tsai et al, 2004).
Studies have suggested that molecular mimicry may explain the
association among chronic inflammatory infiltrates, human
leucocyte antigen and autoimmune disease with the pathogenesis
of OSF and OL (Canniff et al, 1985; Tsai et al, 2004). Many
cytokines have been thought to play important roles in the
pathogenesis of OSF and OL (Chiu et al, 2001). Angiotensin II, the
main peptide of the renin–angiotensin system (RAS), is a renal
growth factor, inducing hyperplasia/hypertrophy depending on the
cell type. It could also be involved in the fibrotic process of the oral
cavity because of its behaviour as a proinflammatory cytokine,
participating in various steps of the inflammatory response
(Mezzano et al, 2001). Previous reports showed that subjects with
DD genotype are associated with significantly higher levels of ACE
and Ang II than those with I/I genotype, and individuals with the
ID genotype have intermediate levels of these two enzymes.
Various immunologic changes are believed to play a role in the
pathogenesis of OSF and OL (Canniff et al, 1985; Mega et al, 2001).
The increase in CD4 complement and cells with HLA-DR in OSF
tissues suggests that most lymphocytes are activated and that the
number of Langerhans cells increases. Haque et al (1997) studied
subjects with OSF with immunohistochemical methods and found
immunocompetent cells to be present in the lesion, with a high
ratio of CD4 to CD8 cells. Therefore, they suggested an ongoing
cellular immune response leading to a possible imbalance of
immunoregulation with eventual local alterations in tissue
architecture. Angiotensin II is also known to play an important
role in immune cells (Nakagawa et al, 2000), Papadopoulos et al
(2000) showed that the ACE D allele in its homozygous form might
confer susceptibility for autoimmune manifestations in sarcoido-
sis. Sato et al (1998) also revealed that the ACE genotype could be
associated with the disease activity of SLE. Thus, subjects with the
ACE gene D allele may, through the increased effect of Ang II, on
cytokine activation, chronic inflammation and immune modula-
tion, contribute to the increased risk of OSF and OL.
Cigarette smokers are more likely to develop many forms of
disease than nonsmokers, including oral diseases. However, our
study did not show an increased risk of precancerous lesions in
smoking betel chewers with ACE gene D allele. Recently, Wang and
co-workers reported that GSTM1 deficiency is associated with the
risk of vascular diseases, while they did not observe any interaction
between the status of cigarette smoking and GSTM1 deficiency in
relation to coronary arterial disease severity (Wang and Wang,
2005). Similar findings were reported by Kelada et al (2000) that
also did not find an interactive effect between smoking and GSTM1
non-null genotype of prostate cancer. Our results show that ACE
gene I/D polymorphism and cigarette smoking status have no
synergistic or additive effect in relation to the risk of OPL. This fact
may suggest that smoking and genetic factors may be differently
involved in the development of OPL disease.
In summary, our study shows an association of the ACE gene I/D
polymorphism with OSF and OL in a Taiwan aboriginal
population. These results imply that susceptibility to OSF and
OL could involve genetic mechanisms modified by betel quid
exposure. The present study also suggests that the RAS may be
involved in the pathophysiology of inflammatory reaction and
immunologic derangement in OSF and OL. Further work is
required to confirm these findings in populations of different races
and these preliminary exploratory results should be confirmed in a
larger study.
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